News Updates
More Articles
- Blueprint for a Connected Regulatory Ecosystem: DIA RIM Reference Model V2.0
- FDA Tightens Expectations for Biosimilar Promotion: Guidance, Warnings, and Policy Proposals
- From Inclusion to Impact: Closing the Female Data Gap in Clinical Trials
- From Policy to Infrastructure: China’s Trusted Data Spaces and the Rise of Decision-Grade Real-World Data and Real-World Evidence
- China's Drive to Expand Domestic Approvals Beyond Its Borders (Chinese version)
